183 related articles for article (PubMed ID: 19846923)
21. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
Abedini MR; Muller EJ; Brun J; Bergeron R; Gray DA; Tsang BK
Cancer Res; 2008 Jun; 68(12):4511-7. PubMed ID: 18559494
[TBL] [Abstract][Full Text] [Related]
22. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
23. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
Lee S; Yoon CY; Byun SS; Lee E; Lee SE
J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
[TBL] [Abstract][Full Text] [Related]
24. A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis.
Mawji IA; Simpson CD; Gronda M; Williams MA; Hurren R; Henderson CJ; Datti A; Wrana JL; Schimmer AD
Cancer Res; 2007 Sep; 67(17):8307-15. PubMed ID: 17804746
[TBL] [Abstract][Full Text] [Related]
25. SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
Zang XP; Pento JT
Anticancer Res; 2008; 28(5A):2733-5. PubMed ID: 19035303
[TBL] [Abstract][Full Text] [Related]
26. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability.
Kaunisto A; Kochin V; Asaoka T; Mikhailov A; Poukkula M; Meinander A; Eriksson JE
Cell Death Differ; 2009 Sep; 16(9):1215-26. PubMed ID: 19343040
[TBL] [Abstract][Full Text] [Related]
27. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
28. Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.
van Houdt IS; Muris JJ; Hesselink AT; Kramer D; Cillessen SA; Moesbergen LM; Vos W; Hooijberg E; Meijer CJ; Kummer JA; Oudejans JJ
Histopathology; 2007 Dec; 51(6):778-84. PubMed ID: 18042067
[TBL] [Abstract][Full Text] [Related]
29. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
Croci DO; Cogno IS; Vittar NB; Salvatierra E; Trajtenberg F; Podhajcer OL; Osinaga E; Rabinovich GA; Rivarola VA
J Cell Biochem; 2008 Oct; 105(2):381-90. PubMed ID: 18553460
[TBL] [Abstract][Full Text] [Related]
30. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.
de Vries JF; von dem Borne PA; van Luxemburg-Heijs SA; Heemskerk MH; Willemze R; Falkenburg JH; Barge RM
Haematologica; 2007 Dec; 92(12):1671-8. PubMed ID: 18055991
[TBL] [Abstract][Full Text] [Related]
31. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
[TBL] [Abstract][Full Text] [Related]
32. Intracellular and extracellular remodeling effectively prevents human CD8(+)cytotoxic T lymphocyte-mediated xenocytotoxicity by coexpression of membrane-bound human FasL and pig c-FLIP(L) in pig endothelial cells.
Tanemura M; Saga A; Kawamoto K; Machida T; Deguchi T; Nishida T; Sawa Y; Doki Y; Mori M; Ito T
Transplant Proc; 2009; 41(1):391-4. PubMed ID: 19249564
[TBL] [Abstract][Full Text] [Related]
33. The nuclear receptor interacting factor-3 transcriptional coregulator mediates rapid apoptosis in breast cancer cells through direct and bystander-mediated events.
Das S; Nwachukwu JC; Li D; Vulin AI; Martinez-Caballero S; Kinnally KW; Samuels HH
Cancer Res; 2007 Feb; 67(4):1775-82. PubMed ID: 17308120
[TBL] [Abstract][Full Text] [Related]
34. Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
Dougherty CJ; Ichim TE; Liu L; Reznik G; Min WP; Ghochikyan A; Agadjanyan MG; Reznik BN
Biochem Biophys Res Commun; 2008 May; 370(1):109-12. PubMed ID: 18355444
[TBL] [Abstract][Full Text] [Related]
35. Nuclear localization of c-FLIP-L and its regulation of AP-1 activity.
Zhang J; Chen Y; Huang Q; Cheng W; Kang Y; Shu L; Yin W; Hua ZC
Int J Biochem Cell Biol; 2009; 41(8-9):1678-84. PubMed ID: 19433309
[TBL] [Abstract][Full Text] [Related]
36. Anti-apoptotic activity of porcine cFLIP in ovarian granulosa cell lines.
Matsuda-Minehata F; Goto Y; Inoue N; Sakamaki K; Chedrese PJ; Manabe N
Mol Reprod Dev; 2007 Sep; 74(9):1165-70. PubMed ID: 17594695
[TBL] [Abstract][Full Text] [Related]
37. Distinctive molecular signaling in triple-negative breast cancer cell death triggered by hexadecylphosphocholine (miltefosine).
Chakrabandhu K; Huault S; Hueber AO
FEBS Lett; 2008 Dec; 582(30):4176-84. PubMed ID: 19041866
[TBL] [Abstract][Full Text] [Related]
38. Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKbeta.
Seo AM; Hong SW; Shin JS; Park IC; Hong NJ; Kim DJ; Lee WK; Lee WJ; Jin DH; Lee MS
Apoptosis; 2009 Jul; 14(7):913-22. PubMed ID: 19526344
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-X(L) and promotes apoptosis of MCF-7 breast cancer cells.
Arakawa Y; Saito S; Yamada H; Aiba K
Apoptosis; 2009 Sep; 14(9):1076-85. PubMed ID: 19641995
[TBL] [Abstract][Full Text] [Related]
40. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
